PEG-MGF
Also known as: PEGylated MGF, PEGylated Mechano Growth Factor
A PEGylated version of MGF with extended half-life for systemic muscle effects.
Overview
PEG-MGF is mechano growth factor (MGF) modified with polyethylene glycol (PEG) to extend its half-life from minutes to hours. This allows for systemic administration rather than local injection, making it more practical for whole-body muscle support.
Mechanism of Action
Same mechanism as MGF - activates muscle satellite cells. PEGylation protects from rapid degradation and extends circulation time. Allows systemic effects rather than just local injection site effects.
Pharmacokinetics
Half-life extended to several hours (vs minutes for MGF). Subcutaneous administration. Systemic distribution.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Muscle Support
200-500 mcg
2-3x weekly
4-6 weeks
Systemic administration
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Extended half-life allows systemic use
- 2Activates satellite cells throughout body
- 3More practical dosing than standard MGF
- 4Still limited human research
Side Effects & Contraindications
Reported Side Effects
- Hypoglycemia (possible)
- Injection site reactions
- Limited long-term data
Contraindications
- Active cancer
- Uncontrolled diabetes
Safety Considerations
Research compound. Longer half-life may increase systemic effects. Monitor for hypoglycemia. Limited safety data.
Storage Requirements
Refrigerate 2-8°C after reconstitution
Scientific References
- 1